Peregrine Pharmaceuticals reported $1.22B in Market Capitalization this September of 2022, considering the latest stock price and the number of outstanding shares.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Market Capitalization Change
Agenus AGEN:US $ 0.52B 0.11B
Amgen AMGN:US $ 129.97B 0.89B
AstraZeneca AZN:LN 16734.4B 1035.33B
Biocryst Pharmaceuticals BCRX:US $ 1.97B 1.04B
Bristol Myers Squibb BMY:US $ 163.94B 8.45B
Celldex Therapeutics CLDX:US $ 1.26B 0.33B
Chemocentryx CCXI:US $ 1.76B 0.02B
Eli Lilly And LLY:US $ 308.07B 35.35B
GlaxoSmithKline GSK:LN 8976.58B 602.38B
Immunogen IMGN:US $ 0.99B 0.06B
Intrexon XON:US $ 0.28B 0.16B
Karyopharm Therapeutics KPTI:US $ 0.36B 0.22B
Macrogenics MGNX:US $ 0.18B 0.36B
Mannkind MNKD:US $ 0.96B 0.03B
Merk MRK:US $ 230.55B 23.1B
Minerva Neurosciences NERV:US $ 0.02B 0.02B
Newlink Genetics NLNK:US $ 0.06B 0.01B
Novartis NOVN:VX 194.34B 3.46B
Novavax NVAX:US $ 4.02B 1.6B
Peregrine Pharmaceuticals PPHM:US $ 0.94B 0.31B
Repligen RGEN:US $ 9B 1.4B
Roche Holding ROG:VX 300.5B 1.25B
Xencor XNCR:US $ 1.63B 0.05B